Suchergebnisse - "Tabernero, J"

PubPharm (85)

1

Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Ros, J. | Matito, J. | Villacampa, G. | +17

2

Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer

enthalten in: ESMO open | 2022

von Van Cutsem, E. | Hochster, H. | Shitara, K. | +11

3

Antitumor activity of lurbinectedin in combination with oral capecitabine in patients with metastatic breast cancer

enthalten in: ESMO open | 2022

von Awada, A. | Boni, V. | Moreno, V. | +7

4

A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Argilés, G. | Mulet, N. | Valladares-Ayerbes, M. | +58

5

Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumors

enthalten in: ESMO open | 2022

von Le Tourneau, C. | Becker, H. | Claus, R. | +10

6

MODUL cohort 2 : an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAFwt metastatic colorectal cancer

enthalten in: ESMO open | 2022

von Tabernero, J. | Grothey, A. | Arnold, D. | +8

7

Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors

enthalten in: ESMO open | 2022

von Borazanci, E. | Schram, A. | Garralda, E. | +20

8

Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer : patient-reported outcomes from BEACON CRC

enthalten in: ESMO open | 2022

von Kopetz, S. | Grothey, A. | Van Cutsem, E. | +14

9

Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody-drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors : first-in-human dose-escalation study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Gazzah, A. | Bedard, P. | Hierro, C. | +9

10

Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers

enthalten in: ESMO open | 2022

von Tabernero, J. | Andre, F. | Blay, J. | +7

1
2
3
4
5
6
7
8
9
Nächster »
[9]